This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Balagopal, P. Articles by George, D. Search for Related Content PubMed PubMed Citation Articles by Balagopal, P. Articles by George, D. Related Collections Pediatric Endocrinology Diabetes and Insulin Metabolism

Reduction of Elevated Serum Retinol Binding Protein in Obese Children by Lifestyle Intervention: Association with Subclinical Inflammation

Nemours Children’s Clinic (P.B., A.A., V.F., D.G.) and Mayo Clinic College of Medicine (P.B.), Jacksonville, Florida 32207; and Division of Endocrinology, Diabetes, and Metabolism (T.E.G., B.B.K.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215

Address all correspondence and requests for reprints to: Prabhakaran Balagopal, Ph.D., Nemours Children’s Clinic, 807 Children’s Way, Jacksonville, Florida 32207. E-mail: bbalagop{at}nemours.org.

Context: Retinol binding protein (RBP4), secreted primarily from the liver and adipose tissues, was recently proposed as a link between obesity and insulin resistance. The role of RBP4 in pediatric obesity, its relationship with subclinical inflammation, and its response to lifestyle changes are not elucidated.

Objective: The objective of the study was to determine in children: 1) the status of RBP4 levels in lean vs. obese; 2) the relationship between RBP4 levels and subclinical inflammation; and 3) the effect of lifestyle-only intervention on RBP4 levels.

Design, Setting, and Patients: Lean and obese children (n = 21) matched for age (>14 yr to < 18 yr) and maturity stage (Tanner IV) were studied at baseline and with lifestyle intervention in obese subjects only (n = 15).

Intervention: Patients received 3 months of randomized and controlled physical activity-based lifestyle intervention.

Main Outcome Measure: RBP4 levels in children before and after intervention and the relationship between RBP4 and subclinical inflammation were measured.

Results: Higher RBP4 levels were found in the obese group vs. lean group (P = 0.005). RBP4 correlated with not only indices of obesity and insulin resistance but also inflammatory factors (r = 0.63 and 0.64 for C-reactive protein and IL-6, respectively, P < 0.01). Intervention reduced RBP4 levels by approximately 30% (P = 0.001), and RBP4 reduction was correlated with the magnitude of decrease in inflammatory factors (P = 0.01).

Conclusion: Alterations in serum RBP4 occur at an early age in the clinical course of obesity and appear to correlate with subclinical inflammation. Lifestyle intervention almost entirely reversed the raised RBP4 levels in obese children. Future studies should determine whether elevation of RBP4 is a direct trigger for the insulin resistance and subclinical inflammation implicated in the premature development of cardiovascular disease and diabetes.

This article has been cited by other articles:

				Z. Yu, X. Ye, J. Wang, Q. Qi, O. H. Franco, K. L. Rennie, A. Pan, H. Li, Y. Liu, F. B. Hu, et al. Associations of Physical Activity With Inflammatory Factors, Adipocytokines, and Metabolic Syndrome in Middle-Aged and Older Chinese People Circulation, June 16, 2009; 119(23): 2969 - 2977. [Abstract] [Full Text] [PDF]

				E. Ingelsson and L. Lind Circulating Retinol-Binding Protein 4 and Subclinical Cardiovascular Disease in the Elderly Diabetes Care, April 1, 2009; 32(4): 733 - 735. [Abstract] [Full Text] [PDF]

				H. Wu, L. Wei, Y. Bao, J. Lu, P. Huang, Y. Liu, W. Jia, and K. Xiang Fenofibrate reduces serum retinol-binding protein-4 by suppressing its expression in adipose tissue Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E628 - E634. [Abstract] [Full Text] [PDF]

				A. O. Chavez, D. K. Coletta, S. Kamath, D. T. Cromack, A. Monroy, F. Folli, R. A. DeFronzo, and D. Tripathy Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E758 - E764. [Abstract] [Full Text] [PDF]

				A. Motani, Z. Wang, M. Conn, K. Siegler, Y. Zhang, Q. Liu, S. Johnstone, H. Xu, S. Thibault, Y. Wang, et al. Identification and Characterization of a Non-retinoid Ligand for Retinol-binding Protein 4 Which Lowers Serum Retinol-binding Protein 4 Levels in Vivo J. Biol. Chem., March 20, 2009; 284(12): 7673 - 7680. [Abstract] [Full Text] [PDF]

				Z. Mallat, T. Simon, J. Benessiano, K. Clement, S. Taleb, N. J. Wareham, R. Luben, K.-T. Khaw, A. Tedgui, and S. M. Boekholdt Retinol-Binding Protein 4 and Prediction of Incident Coronary Events in Healthy Men and Women J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 255 - 260. [Abstract] [Full Text] [PDF]

				R. Ribel-Madsen, M. Friedrichsen, A. Vaag, and P. Poulsen Retinol-Binding Protein 4 in Twins: Regulatory Mechanisms and Impact of Circulating and Tissue Expression Levels on Insulin Secretion and Action Diabetes, January 1, 2009; 58(1): 54 - 60. [Abstract] [Full Text] [PDF]

				N. Stefan, K. Kantartzis, and H.-U. Haring Causes and Metabolic Consequences of Fatty Liver Endocr. Rev., December 1, 2008; 29(7): 939 - 960. [Abstract] [Full Text] [PDF]

				J. P. Mills, H. C. Furr, and S. A. Tanumihardjo Retinol to Retinol-Binding Protein (RBP) Is Low in Obese Adults due to Elevated apo-RBP Experimental Biology and Medicine, October 1, 2008; 233(10): 1255 - 1261. [Abstract] [Full Text] [PDF]

				S. H. Choi, S. H. Kwak, B.-S. Youn, S. Lim, Y. J. Park, H. Lee, N. Lee, Y. M. Cho, H. K. Lee, Y.-B. Kim, et al. High Plasma Retinol Binding Protein-4 and Low Plasma Adiponectin Concentrations Are Associated with Severity of Glucose Intolerance in Women with Previous Gestational Diabetes Mellitus J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3142 - 3148. [Abstract] [Full Text] [PDF]

				T. M. Barber, M. Hazell, C. Christodoulides, S. J. Golding, C. Alvey, K. Burling, A. Vidal-Puig, N. P. Groome, J. A. H. Wass, S. Franks, et al. Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2859 - 2865. [Abstract] [Full Text] [PDF]

				C. Kanaka-Gantenbein, A. Margeli, P. Pervanidou, S. Sakka, G. Mastorakos, G. P. Chrousos, and I. Papassotiriou Retinol-Binding Protein 4 and Lipocalin-2 in Childhood and Adolescent Obesity: When Children Are Not Just "Small Adults" Clin. Chem., July 1, 2008; 54(7): 1176 - 1182. [Abstract] [Full Text] [PDF]

				T. Reinehr, B. Stoffel-Wagner, and C. L. Roth Retinol-Binding Protein 4 and Its Relation to Insulin Resistance in Obese Children before and after Weight Loss J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2287 - 2293. [Abstract] [Full Text] [PDF]

				S. de Ferranti and D. Mozaffarian The Perfect Storm: Obesity, Adipocyte Dysfunction, and Metabolic Consequences Clin. Chem., June 1, 2008; 54(6): 945 - 955. [Abstract] [Full Text] [PDF]

				M. Mohlig, M. O Weickert, E. Ghadamgahi, A. M Arafat, J. Spranger, A. F H Pfeiffer, and C. Schofl Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome. Eur. J. Endocrinol., April 1, 2008; 158(4): 517 - 523. [Abstract] [Full Text] [PDF]

				N. Mody, T. E. Graham, Y. Tsuji, Q. Yang, and B. B. Kahn Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E785 - E793. [Abstract] [Full Text] [PDF]

				Q. Qi, Z. Yu, X. Ye, F. Zhao, P. Huang, F. B. Hu, O. H. Franco, J. Wang, H. Li, Y. Liu, et al. Elevated Retinol-Binding Protein 4 Levels Are Associated with Metabolic Syndrome in Chinese People J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4827 - 4834. [Abstract] [Full Text] [PDF]

				I. Aeberli, R. Biebinger, R. Lehmann, D. l'Allemand, G. A. Spinas, and M. B. Zimmermann Serum Retinol-Binding Protein 4 Concentration and Its Ratio to Serum Retinol Are Associated with Obesity and Metabolic Syndrome Components in Children J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4359 - 4365. [Abstract] [Full Text] [PDF]

				M. Ziegelmeier, A. Bachmann, J. Seeger, U. Lossner, J. Kratzsch, M. Bluher, M. Stumvoll, and M. Fasshauer Serum Levels of Adipokine Retinol-Binding Protein-4 in Relation to Renal Function Diabetes Care, October 1, 2007; 30(10): 2588 - 2592. [Abstract] [Full Text] [PDF]